Preinduction Serum Vitamin D3 Levels and Induction Chemotherapy Remission Rates in Patients with Acute Leukemia

References

• Kulling PM, Olson KC, Olson TL, Feith DJ, Loughran TP, Jr. Vitamin D in hematological disorders and malignancies. Eur J Haematol. 2017;98(3):187–197. doi:10.1111/ejh.12818
   PubMed Web of Science ®Google Scholar
• Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013;5(10):3993–4021. doi:10.3390/nu5103993
   PubMed Web of Science ®Google Scholar
• Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J. 2012;441(1):61–76. doi:10.1042/BJ20110744
   PubMed Web of Science ®Google Scholar
• Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50(4):1–14.
   Google Scholar
• Tavera-Mendoza LE, Westerling T, Libby E, Marusyk A, Cato L, et al. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proc Natl AcadSci USA. 2017;114(11):E2186–E2194.
   PubMed Web of Science ®Google Scholar
• Thomas X, Chelghoum Y, Fanari N, Cannas G. Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies. Hematology. 2011;16(5):278–283. doi:10.1179/102453311X13085644679908
   PubMed Web of Science ®Google Scholar
• Naz A, N Qureshi R, S Shamsi T, Mahboob T. Vitamin D levels in patients of acute leukemia before and after remission-induction therapy. Pak J Med Sci. 2013;29(1):10–14. doi:10.12669/pjms.291.2764
   PubMed Web of Science ®Google Scholar
• Lee HJ, Muindi JR, Tan W, Hu Q, Wang D, Liu S, Wilding GE, Ford LA, Sait SNJ, Block AW, et al. Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Cancer. 2014;120(4):521–529. doi:10.1002/cncr.28368
   PubMed Web of Science ®Google Scholar
• Seyedalipour F, Mansouri A, Vaezi M, Gholami K, Heidari K, et al. A high prevalence of vitamin D deficiency in newly diagnosed acute myeloid leukemia patients and its adverse outcome. Int J HematolOncol Stem Cell Res. 2017;11(3):209–216.
   PubMedGoogle Scholar
• Frangou CG, Den Haese J, Nowak N, Johnson CS, Trump D, Wetzler M. 25(OH) Vitamin D3 affects acute myeloid leukemia cell proliferation. Blood. 2013;122(21):5026. doi:10.1182/blood.V122.21.5026.5026
   Web of Science ®Google Scholar
• Ghali HS, Al-Gareeb R, Faraj A. Safa: effect of induction chemotherapy on vitamin D level in children with acute leukemia. Int J Pharm Sci Res. 2020;11(3):1367–1372.
   Web of Science ®Google Scholar
• Van Schoor NM, Lips P. Worldwide Vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25(4):671–680. doi:10.1016/j.beem.2011.06.007
   PubMed Web of Science ®Google Scholar
• Mithal A, Wahl DA, Bonjour J-P, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, IOF Committee of Scientific Advisors (CSA) Nutrition Working Group, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20(11):1807–1820. doi:10.1007/s00198-009-0954-6
   PubMed Web of Science ®Google Scholar
• van der Meer IM, Middelkoop BJC, Boeke AJP, Lips P. Lips P: prevalence of vitamin D deficiency among Turkish, Moroccan, Indian and sub-Sahara African populations in Europe and their countries of origin: An overview. Osteoporos Int. 2011;22(4):1009–1021. doi:10.1007/s00198-010-1279-1
   PubMed Web of Science ®Google Scholar
• Tandon N, Marwaha RK, Kalra S, Gupta N, Dudha A, Kochupillai N. Bone mineral parameters in healthy young Indian adults with optimal vitamin D availability. Natl Med J India. 2003;16(6):298–302.
   PubMed Web of Science ®Google Scholar
• Beloyartseva M, Mithal A, Kaur P, Kalra S, Baruah MP, Mukhopadhyay S, Bantwal G, Bandgar TR. Widespread vitamin D deficiency among Indian health care professionals. Arch Osteoporos. 2012;7(1-2):187–192. doi:10.1007/s11657-012-0096-x
   PubMedGoogle Scholar
• G R, Gupta A. Vitamin D deficiency in India: Prevalence, causalities and interventions. Nutrients. 2014;6(2):729–775. doi:10.3390/nu6020729
   PubMed Web of Science ®Google Scholar
• Edlich R, Mason SS, Chase ME, Fisher AL, Gubler K. Scientific documentation of the relationship of vitamin D deficiency and the development of cancer. J Environ PatholToxicol Oncol. 2009;28(2):133–141.
   PubMed Web of Science ®Google Scholar
• Goswami R, Gupta N, Goswami D, Marwaha RK, Tandon N, Kochupillai N. Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr. 2000;72(2):472–475. doi:10.1093/ajcn/72.2.472
   PubMed Web of Science ®Google Scholar
• Zargar AH, Ahmad S, Masoodi SR, Wani AI, Bashir MI, Laway BA, Shah ZA. Vitamin D status in apparently healthy adults in Kashmir Valley of Indian subcontinent. Postgrad Med J. 2007;83(985):713–716. doi:10.1136/pgmj.2007.059113
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Drake MT, Maurer MJ, Allmer C, Rabe KG, Slager SL, Weiner GJ, Call TG, Link BK, Zent CS, et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood. 2011;117(5):1492–1428. doi:10.1182/blood-2010-07-295683
   PubMed Web of Science ®Google Scholar
• Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, Micallef IN, Kelly JL, Macon WR, Nowakowski GS, Inwards DJ, et al. Vitamin D insufficiency and prognosis in non-Hodgkin’s lymphoma. JCO. 2010;28(27):4191–4198. doi:10.1200/JCO.2010.28.6674
   PubMed Web of Science ®Google Scholar
• Eissa D, Moussa M, Elkerdany T. Moussa Mohamed M: Serum 25-hydroxyvitamin D levels in relation to disease status and prognosis in acute myeloid leukemia. Egypt J Haematol. 2014;39(2):47–51. doi:10.4103/1110-1067.139757
   Google Scholar